A Pair of Prognostic Biomarkers in Triple-Negative Breast Cancer: KLK10 and KLK11 mRNA Expression

Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype with poor patient prognosis and limited therapeutic options. A lack of prognostic biomarkers and therapeutic targets fuels the need for new approaches to tackle this severe disease. Extracellular matrix degradation, release,...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Life (Basel, Switzerland) Jg. 12; H. 10; S. 1517
Hauptverfasser:	Liu, Yueyang, Gong, Weiwei, Preis, Sarah, Dorn, Julia, Kiechle, Marion, Reuning, Ute, Magdolen, Viktor, Dreyer, Tobias F.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Basel MDPI AG 28.09.2022 MDPI
Schlagworte:	Biomarkers Breast cancer Cancer therapies Carcinogenesis Carcinogens Chemokines Chemotherapy Cytokines Epidermal growth factor Estrogens Extracellular matrix Gene amplification Gene expression Growth factors Kallikrein KLK10 KLK11 Lymph nodes Medical prognosis Metastases mRNA Ovarian cancer Patients Peptidase Peptidases Polymerase chain reaction Prognosis Prostate Proteolysis Regression analysis Software Statistical analysis Surgery Testicular cancer Therapeutic targets triple-negative breast cancer Tumors
ISSN:	2075-1729, 2075-1729
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!